Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Sermorelin

GHRH (1-29), GRF 1-29 NH2, Sermorelin acetate

A synthetic 29-amino acid analog of growth hormone-releasing hormone that stimulates pituitary gland to release growth hormone.

Quick Stats
Studies 223
Trials 41
Formula C149H246N44O42S
Clear All
Completed PHASE1 NCT03031535

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

Dauntless Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Completed NCT00507104

Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)

University of Erlangen-Nürnberg Medical School
OBSERVATIONAL
Updated Dec 15, 2025
Completed PHASE3 NCT00123253

TH9507 in Patients With HIV-Associated Lipodystrophy

Theratechnologies
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE1 NCT02012556

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

Theratechnologies
INTERVENTIONAL
Updated Dec 15, 2025
Completed NCT00004332

Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly

National Center for Research Resources (NCRR)
OBSERVATIONAL
Updated Dec 15, 2025
Withdrawn NA NCT01632592

Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE2 NCT00257712

SMART: Somatotrophics, Memory, and Aging Research Trial

University of Washington
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE1 NCT01897844

A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers

Italfarmaco
INTERVENTIONAL
Updated Dec 15, 2025
Completed NCT02092779

Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study

University of Roma La Sapienza
OBSERVATIONAL
Updated Dec 15, 2025
Completed NCT02507245

Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)

Stefania La Grutta, MD
OBSERVATIONAL
Updated Dec 15, 2025
Completed PHASE3 NCT00448747

Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.

AEterna Zentaris
INTERVENTIONAL
Updated Dec 15, 2025
Completed NA NCT00324064

Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing

Children's Mercy Hospital Kansas City
INTERVENTIONAL
Updated Dec 15, 2025
Completed NA NCT02196831

Tesamorelin Effects on Liver Fat and Histology in HIV

Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE2 NCT00675506

Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese

Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE4 NCT03226821

Body Composition and Adipose Tissue in HIV

Columbia University
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE4 NCT01701973

Effect of DPP4 Inhibition on Growth Hormone Secretion

Vanderbilt University
INTERVENTIONAL
Updated Dec 15, 2025
Withdrawn NCT01788462

Egrifta Replacement and Sleep Disordered Breathing

Johns Hopkins University
OBSERVATIONAL
Updated Dec 15, 2025
Completed PHASE2 NCT03375788

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Terminated NCT00006073

Endocrine Studies in Health and Disease

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
OBSERVATIONAL
Updated Dec 15, 2025
Completed PHASE1 NCT01359488

VRS-317 in Adult Subjects With Growth Hormone Deficiency

Versartis Inc.
INTERVENTIONAL
Updated Dec 15, 2025